✨ Medicine Distribution Consents




17 SEPTEMBER NEW ZEALAND GAZETTE 3589

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Ammonium chloride 25 mg/mL, diphenhydramine hydrochloride 2.5 mg/mL Syrup PSM Holdings Limited, Wiri, Auckland Diphenacough
Bisacodyl 10 mg Suppository C B Fleet & Co Inc., Lynchburg, Virginia, United States of America Fleet Laxative Suppositories
Metoclopramide hydrochloride 5 mg/mL Injection, solution (syringe and polyamp) Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia Metoclopramide
Ketoconazole 2% w/w Shampoo Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Sebizole
Basiliximab 20 mg
Diluent: Water for injection
Injection, powder with diluent Novartis Pharma AG., Basel, Switzerland
Diluent: Novartis Pharma AG., Stein, Switzerland
Simulect
Cefaclor monohydrate 27.8 mg/mL, 55.6 mg/mL equivalent to 25 mg/mL, 50 mg/mL cefaclor anhydrous Suspension, oral Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India Locef
Cefaclor monohydrate 267.5 mg/mL, 535 mg equivalent to 250 mg, 500 mg cefaclor anhydrous Capsules, powder filled Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India Locef

Dated this 8th day of September 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g06558

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Lamivudine 5 mg/mL Solution, oral Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom Zeffix

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 14th day of September 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g06685

Consent to the Distribution of a Changed Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Lamivudine 100 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Zeffix

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 14th day of September 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g06686



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1998, No 148


NZLII PDF NZ Gazette 1998, No 148





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
8 September 1998
Medicines Act 1981, New Medicine, Distribution
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
14 September 1998
Medicines Act 1981, New Medicine, Provisional Consent, Distribution
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
14 September 1998
Medicines Act 1981, Changed Medicine, Distribution
  • G. R. Boyd, Chief Advisor, Regulation and Safety